Bowel Preparation in Colonoscopy: Lactulose vs Polyethyleneglycol, Randomized Double-blind Comparative Clinical Trial, Multicenter Study.
| 适应症 | Colorectal Cancer Screening |
|---|---|
| 分期 | 4期 |
| 申办方 | Hospital Civil de Guadalajara |
| 状态 | 已完成 |
| 受试者人数 | 449 人 |
| 干预（药物） | Bowel preparation before colonoscopy, Bowel preparation before colonoscopy |
| 开始日期 | 2024年7月20日 |
| 完成日期 | 2025年7月31日 |
| 结果公布日 | 2026年7月28日 |
摘要
The goal of this clinical trial it is to bowel the instestinal preparation with lactulose vs poliethylenglicol as better agent to have a quality colonoscopy and demostrate that lactulose is most efective, has a good tolerance and the patient would have a better satisfaction, so the question is: wich is the eficancy of lactulose in comparision with thepoliethylenglycol in the intestinal preparation for the colonoscopy?
Bowel Cleansing Was Assessed Using the Boston Bowel Preparation Scale (BBPS).
| Bowel Preparation With Lactulose Before de Colonoscopy | 7.21 ± 1.61 Score scale |
|---|---|
| Bowel Preparation With Plyethylenglycol Before the Colonoscopy | 7.08 ± 1.49 Score scale |
在 BENITIONS 中查看 查看 ClinicalTrials.gov 原文
同一适应症的其他试验
- CryoBalloon Ablation for Treatment of Duodenal Adenomas — Johns Hopkins University
- Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refract — Jennerex Biotherapeutics
- Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III — National Cancer Institute (NCI)
- Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps — National Cancer Institute (NCI)
- Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal — National Cancer Institute (NCI)
- Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating — National Cancer Institute (NCI)